Ignite Creation Date:
2024-05-05 @ 6:37 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00513201
Status:
COMPLETED
Last Update Posted:
2007-08-08
First Post:
2007-08-07
Brief Title:
Lyspro Insulin vs Regular Insulin in Cirrhotic Patients
Sponsor:
University of Campania Luigi Vanvitelli
Organization:
University of Campania Luigi Vanvitelli
Study Overview
Official Title:
None
Status:
COMPLETED
Status Verified Date:
2007-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
OBJECTIVE To compare lispro insulin and regular insulin in the glycemic control of patients with liver cirrhosis and type 2 diabetes subjects METHODS 108 patients with liver cirrhosis and type 2 diabetes were randomly treated with regular insulin or lispro After 122 weeks a cross-over was carried out and patients followed-up for 122 weeks Then all patients received a standard breakfast of 145 kcal following 12 UI of regular insulin or lispro and C-peptide and insulin serum levels were determined over 300 minutes
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None